Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Brogan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Organic Chemistry|July 4, 2003
Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological propertiesAndrew P Brogan, William R Widger, Harold Kohn
Pharmacoeconomics|March 23, 2013
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw, Andrew P Brogan, Cheryl L McDade
Chemical Communications (Cambridge, England)|March 26, 2008
Nornicotine-organocatalyzed aqueous reduction of alpha,beta-unsaturated aldehydesAndrew P Brogan, Tobin J Dickerson, Kim D Janda
Journal of Inorganic Biochemistry|February 15, 2005
Bismuth-dithiol inhibition of the Escherichia coli rho transcription termination factorAndrew P Brogan, Jacob Verghese, William R Widger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Altered retinoid homeostasis catalyzed by a nicotine metabolite: implications in macular degeneration and normal developmentAndrew P Brogan, Tobin J Dickerson, Grant E Boldt, et al.
The Journal of Organic Chemistry|April 23, 2005
Hammett correlation of nornicotine analogues in the aqueous aldol reaction: implications for green organocatalysisClaude J Rogers, Tobin J Dickerson, Andrew P Brogan, et al.
Structure (London, England : 1993)|January 12, 2005
Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycinEmmanuel Skordalakes, Andrew P Brogan, Boon Saeng Park, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United StatesAndrew P Brogan, Susan L Hogue, Renu M Vekaria, et al.
The Patient|October 8, 2025
PAIRED: Quantitative and Qualitative PAtIent-Reported Experiences and perceiveD Benefit of Treatment with Dolutegravir/Lamivudine in the United StatesJihad Slim, Andrew P Brogan, Gavin Harper, et al.
Journal of the American Chemical Society|March 6, 2007
Antibody-catalyzed oxidation of delta(9)-tetrahydrocannabinolAndrew P Brogan, Lisa M Eubanks, George F Koob, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|July 4, 2003
Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological propertiesAndrew P Brogan, William R Widger, Harold Kohn
Pharmacoeconomics|March 23, 2013
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw, Andrew P Brogan, Cheryl L McDade
Chemical Communications (Cambridge, England)|March 26, 2008
Nornicotine-organocatalyzed aqueous reduction of alpha,beta-unsaturated aldehydesAndrew P Brogan, Tobin J Dickerson, Kim D Janda
Journal of Inorganic Biochemistry|February 15, 2005
Bismuth-dithiol inhibition of the Escherichia coli rho transcription termination factorAndrew P Brogan, Jacob Verghese, William R Widger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Altered retinoid homeostasis catalyzed by a nicotine metabolite: implications in macular degeneration and normal developmentAndrew P Brogan, Tobin J Dickerson, Grant E Boldt, et al.
The Journal of Organic Chemistry|April 23, 2005
Hammett correlation of nornicotine analogues in the aqueous aldol reaction: implications for green organocatalysisClaude J Rogers, Tobin J Dickerson, Andrew P Brogan, et al.
Structure (London, England : 1993)|January 12, 2005
Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycinEmmanuel Skordalakes, Andrew P Brogan, Boon Saeng Park, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United StatesAndrew P Brogan, Susan L Hogue, Renu M Vekaria, et al.
The Patient|October 8, 2025
PAIRED: Quantitative and Qualitative PAtIent-Reported Experiences and perceiveD Benefit of Treatment with Dolutegravir/Lamivudine in the United StatesJihad Slim, Andrew P Brogan, Gavin Harper, et al.
Journal of the American Chemical Society|March 6, 2007
Antibody-catalyzed oxidation of delta(9)-tetrahydrocannabinolAndrew P Brogan, Lisa M Eubanks, George F Koob, et al.
Pageof 2